Open access
66
Views
6
CrossRef citations to date
0
Altmetric
Original Research
Improvement in 24-hour bronchodilation and symptom control with aclidinium bromide versus tiotropium and placebo in symptomatic patients with COPD: post hoc analysis of a Phase IIIb study
Jutta Beier1 insaf Respiratory Research Institute, Wiesbaden, GermanyCorrespondence[email protected]
, Robert Mroz2 Centrum Medycyny Oddechowej;3 Medical University of Białystok, Białystok, Poland
, Anne-Marie Kirsten4 Pulmonary Research Institute at LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany
, Ferran Chuecos5 AstraZeneca PLC, Barcelona, Spain
& Esther Garcia Gil5 AstraZeneca PLC, Barcelona, Spain
Pages 1731-1740
|
Published online: 14 Jun 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.